Publicacións nas que colabora con José Alberto Orfao de Matos Correia e Vale (11)

2024

  1. Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients

    Blood cancer journal

2013

  1. Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish Cooperative Group

    Annals of Hematology, Vol. 92, Núm. 9, pp. 1151-1179

2012

  1. Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients

    Leukemia, Vol. 26, Núm. 8, pp. 1862-1869

2011

  1. Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma

    Leukemia, Vol. 25, Núm. 4, pp. 697-706

2010

  1. Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era

    European Journal of Haematology, Vol. 85, Núm. 4, pp. 321-328

2002

  1. Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: A tool for comparing the efficacy of different treatment strategies and predicting outcome

    Blood, Vol. 99, Núm. 5, pp. 1853-1856

1999

  1. Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation

    Bone Marrow Transplantation, Vol. 24, Núm. 12, pp. 1279-1283

1998

  1. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients: Implications for the differential diagnosis between MGUS and multiple myeloma

    American Journal of Pathology, Vol. 152, Núm. 6, pp. 1655-1665

1997

  1. Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients

    Blood, Vol. 90, Núm. 6, pp. 2465-2470

  2. Minimal number of circulating CD34+ cells to assure successful leukapheresis and engraftment in peripheral blood progenitor cell transplantation

    Infusionstherapie und Transfusionsmedizin, Vol. 24, Núm. 4, pp. 234

1995

  1. In vitro autonomous proliferation in ANLL: Clinical and biological significance

    Leukemia Research, Vol. 19, Núm. 6, pp. 411-416